Neuroscience • 27 March 2017
London • United Kingdom

Hilary Evans

  • CEO, Alzheimer’s Research UK

Hilary is Chief Executive of Alzheimer’s Research UK, which is a charity working at a global level towards a world where people are free from the fear, harm and heartbreak of dementia. The organisation’s aim is to raise awareness of the diseases that cause dementia, to increase dementia research funding and improve the environment for dementia scientists in the UK and internationally. Alzheimer’s Research UK is at the forefront of challenging people’s perceptions of dementia, finding innovative ways of communicating and creating new platforms to engage the public in a united fight to defeat dementia.

Hilary joined Alzheimer’s Research UK in 2013 to drive forward the organisation’s profile and influence, working closely with the G8 and the World Dementia Council as part of a global commitment to find treatments by 2025. As part of this program, Hilary is pioneering new ways of supporting research, including setting up the Dementia Drug Discovery Institutes, the Global Clinical Trials Fund and the Global Dementia Discovery Fund. Hilary has a strong background in the charity sector, having previously worked for Age UK and Age Concern, and started her career as an advisor to the UK government. Hilary has also worked in policy roles for pharmaceutical companies, advising on patient advocacy and market access issues.

This speaker appears at these events: